16 years of historical data (2010–2025) · Real Estate · REIT - Healthcare Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
On a free-cash-flow basis, the stock trades at 14.8x P/FCF, 33% above the 5-year average of 11.2x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $5.2B | $4.6B | $4.1B | $3.3B | $2.9B | $3.0B | $3.6B | $4.0B | $2.9B | $2.0B | $1.6B |
| Enterprise Value | $6.4B | $5.8B | $6.5B | $5.7B | $5.4B | $5.3B | $6.0B | $6.4B | $6.1B | $4.9B | $2.8B |
| P/E Ratio → | — | — | 32.07 | 241.46 | — | — | 25.93 | 57.68 | 10.56 | 13.41 | 26.54 |
| P/S Ratio | 6.68 | 5.98 | 5.81 | 5.13 | 4.59 | 5.21 | 6.01 | 6.01 | 4.72 | 4.90 | 6.14 |
| P/B Ratio | 1.78 | 1.64 | 1.49 | 1.19 | 0.94 | 0.88 | 1.06 | 1.15 | 0.90 | 0.58 | 1.58 |
| P/FCF | 14.84 | 13.28 | 13.17 | 11.05 | 9.09 | 9.19 | 14.44 | 10.78 | 6.52 | — | 9.05 |
| P/OCF | 14.84 | 13.28 | 13.17 | 11.05 | 9.09 | 8.32 | 10.15 | 10.78 | 8.21 | 14.88 | 9.05 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Sabra Health Care REIT, Inc.'s enterprise value stands at 18.7x EBITDA, 28% above its 5-year average of 14.5x. The Real Estate sector median is 13.6x, placing the stock at a 37% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 7.51 | 9.20 | 8.85 | 8.60 | 9.30 | 9.96 | 9.65 | 9.83 | 11.99 | 10.69 |
| EV / EBITDA | 18.68 | 17.09 | 15.17 | 14.15 | 12.71 | 13.59 | 14.33 | 9.10 | 9.99 | 12.54 | 10.97 |
| EV / EBIT | — | — | 26.64 | 44.49 | 184.50 | — | 24.90 | 18.63 | 14.27 | 19.65 | 20.46 |
| EV / FCF | — | 16.68 | 20.84 | 19.05 | 17.01 | 16.41 | 23.93 | 17.31 | 13.56 | — | 15.76 |
Margins and return-on-capital ratios measuring operating efficiency
Operating margins have expanded from 34.2% to 36.5% over the past 3 years, signaling improving operational efficiency. ROE of 5.6% is modest.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 67.7% | 69.8% | 74.0% | 75.2% | 78.0% | 83.6% | 92.1% | 95.6% | 97.8% |
| Operating Margin | — | — | 36.5% | 34.2% | 37.6% | 37.0% | — | 79.0% | 49.2% | 55.3% | 61.8% |
| Net Profit Margin | 20.0% | 20.0% | 18.0% | 2.1% | -12.4% | -19.9% | 23.1% | 10.3% | 44.8% | 39.0% | 27.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.6% | 5.6% | 4.6% | 0.5% | -2.4% | -3.3% | 4.0% | 2.0% | 8.3% | 7.1% | 6.8% |
| ROA | 2.9% | 2.9% | 2.4% | 0.2% | -1.3% | -1.9% | 2.3% | 1.1% | 4.1% | 3.4% | 3.0% |
| ROIC | — | — | 3.7% | 3.1% | 3.1% | 2.8% | — | 6.4% | 3.6% | 4.0% | 5.2% |
| ROCE | — | — | 5.0% | 4.2% | 4.2% | 3.6% | — | 8.3% | 4.5% | 4.9% | 6.9% |
Solvency and debt-coverage ratios — lower is generally safer
Sabra Health Care REIT, Inc. carries a Debt/EBITDA ratio of 3.7x, which is moderately leveraged (45% below the sector average of 6.7x). Net debt stands at $1.2B ($1.3B total debt minus $72M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.45 | 0.45 | 0.89 | 0.87 | 0.83 | 0.72 | 0.71 | 0.71 | 0.99 | 0.99 | 1.19 |
| Debt / EBITDA | 3.69 | 3.69 | 5.73 | 6.04 | 6.03 | 6.27 | 5.84 | 3.50 | 5.27 | 8.75 | 4.77 |
| Net Debt / Equity | — | 0.42 | 0.87 | 0.86 | 0.82 | 0.69 | 0.69 | 0.70 | 0.98 | 0.84 | 1.17 |
| Net Debt / EBITDA | 3.48 | 3.48 | 5.59 | 5.94 | 5.91 | 5.98 | 5.68 | 3.43 | 5.19 | 7.42 | 4.67 |
| Debt / FCF | — | 3.40 | 7.68 | 8.00 | 7.92 | 7.23 | 9.49 | 6.53 | 7.04 | — | 6.70 |
| Interest Coverage | — | — | 2.23 | 1.96 | 2.23 | 2.14 | — | 4.17 | 2.09 | 2.54 | 2.48 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.15x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.78x to 0.15x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.15 | 0.15 | 0.88 | 0.78 | 0.59 | 1.78 | — | — | 3.59 | 8.49 | 6.46 |
| Quick Ratio | 0.15 | 0.15 | 0.88 | 0.78 | 0.59 | 1.78 | — | — | 3.59 | 8.49 | 6.46 |
| Cash Ratio | 0.06 | 0.06 | 0.27 | 0.18 | 0.15 | 0.78 | — | — | 0.53 | 5.06 | 0.65 |
| Asset Turnover | — | 0.14 | 0.13 | 0.12 | 0.11 | 0.10 | 0.10 | 0.11 | 0.09 | 0.06 | 0.11 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Sabra Health Care REIT, Inc. returns 5.8% to shareholders annually primarily through dividends.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 5.8% | 6.3% | 6.9% | 8.4% | 9.7% | 8.9% | 7.7% | 8.4% | 11.0% | 9.2% | 7.5% |
| Payout Ratio | — | — | 221.1% | 2016.9% | — | — | 201.1% | 486.2% | 116.5% | 115.0% | 169.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 3.1% | 0.4% | — | — | 3.9% | 1.7% | 9.5% | 7.5% | 3.8% |
| FCF Yield | 6.7% | 7.5% | 7.6% | 9.0% | 11.0% | 10.9% | 6.9% | 9.3% | 15.3% | — | 11.0% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.1% | 0.2% | 0.0% | 0.0% | 0.0% | 4.9% | 0.0% | 0.0% |
| Total Shareholder Yield | 5.8% | 6.3% | 6.9% | 8.4% | 9.8% | 8.9% | 7.7% | 8.4% | 15.9% | 9.2% | 7.5% |
| Shares Outstanding | — | $244M | $236M | $233M | $231M | $219M | $207M | $188M | $179M | $106M | $66M |
Compare SBRA with 5 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| SBRAYou | $5B | — | 18.7 | 14.8 | — | — | 5.6% | — | 3.7 |
| OHI | $13B | 31.1 | 18.5 | 18.0 | 98.6% | 62.7% | 9.6% | 5.7% | 5.0 |
| CTRE | $9B | 25.9 | 15.7 | 23.0 | 98.9% | 98.7% | 9.2% | 10.1% | — |
| NHI | $4B | 27.8 | -0.2 | 17.2 | — | — | 9741.4% | — | — |
| LTC | $2B | 15.7 | 10.4 | 14.1 | 96.9% | 79.4% | 10.7% | 8.9% | 2.6 |
| STRW | $168M | 22.5 | 8.3 | 4.8 | 87.0% | 52.4% | 6.3% | 7.2% | 7.0 |
| Real Estate Median | — | 23.4 | 13.6 | 13.7 | 60.4% | 22.0% | 3.3% | 2.6% | 6.7 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 16 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how SBRA stacks up against sector leader Omega Healthcare Investors, Inc..
Start ComparisonSabra Health Care REIT, Inc.'s current EV/EBITDA is 18.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.3x.
Sabra Health Care REIT, Inc.'s return on equity (ROE) is 5.6%. The historical average is 4.5%.
Based on historical data, Sabra Health Care REIT, Inc. is trading at valuation metrics that vary. Compare with industry peers and growth rates for a complete picture.
Sabra Health Care REIT, Inc.'s current dividend yield is 5.76%.
Sabra Health Care REIT, Inc.'s Debt/EBITDA ratio is 3.7x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.